Search:

Clinical Trials & Medical Discoveries Headlines from PR Newswire


< Go Back

Phase 3 DECISION Trial of NEXAVAR (sorafenib) in Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory to Radioactive Iodine Published in The Lancet
Adamas Pharmaceuticals Announces Data Update At American Academy Of Neurology Annual Meeting
New Tuberculosis Drug Regimen Will Move to Landmark Phase 3 Clinical Trial
CheckIssuing joins the Pharmaceutical Marketing Research Group
Society for Clinical Research Sites Launches the Site Advocacy Group Initiative
MiMedx at SAWC Spring 2014: Multiple Studies And Clinical Experience Demonstrate Clinical And Cost Effectiveness Of EpiFix Allograft For Treatment Of Hard-to-Heal Wounds
New Drugs Offer Hope for Migraine Prevention
Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting
AbbVie to Present Data on Investigational Compounds at the 2014 American Society of Clinical Oncology Annual Meeting
Lpath and Walter Reed Army Institute for Research Begin Efficacy Study Using Lpathomab in Traumatic Brain Injury Models
Synthetic Biologics' Reports Preclinical Data to Support Clinical Development of Novel Pertussis Therapeutic
OncoGenex Announces Fast Track Designation Granted for Custirsen in Combination with Cabazitaxel/Prednisone as Second-line Chemotherapy in Phase 3 AFFINITY Trial of Men with Metastatic Castrate-Resistant Prostate Cancer
Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
Greenphire Releases New Visual Analytics Features for eClinicalGPS
Nephrologists Indicate that Improvement in Renal Anemia Parameters is One of the Top Three Efficacy Attributes for a New Hyperphosphatemia Treatment
Boston Scientific Begins Clinical Trial of ACUITY™ X4 LV Pacing Leads and RELIANCE™ 4-FRONT ICD Leads
Dominion Diagnostics Chief Scientific Advisor Kenneth Blum, PhD Receives 2014 ASAM Medical-Scientific Program Committee Award for Best Scientific Abstract
DC Brands Plans to Provide Laboratory Testing Services to the Colorado Marijuana Industry
NeuroPhage Discovers GAIM-changing Molecules to Combat Alzheimer's Disease and Other Neurodegenerative Disorders
AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C
eClinical Insights Leverages Logi Analytics for Clinical Intelligence
PRESENTATION ON NW BIO'S DCVAX-DIRECT TRIAL ANNOUNCED FOR ASCO ANNUAL MEETING
Narrowing of Neck Artery Without Warning May Signal Memory and Thinking Decline
ImmunoCellular Therapeutics Announces ICT-107 Phase II Data Abstract Accepted for Oral Presentation at the 2014 ASCO Annual Meeting
Low Tolerance for Pain? The Reason May Be In Your Genes
New Data From Upsher-Smith's Epilepsy Portfolio To Be Highlighted At The 66th Annual Meeting Of The American Academy Of Neurology English
BioCision's Proprietary Temperature Standardization Technology to be used in TxCell Phase IIb Cell Therapy Clinical Trial in the Treatment of Crohn's Disease
Clinical Trial Results Indicate Acthar May Significantly Reduce Proteinuria in Patients with Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy
Symposium Featuring CardioFocus HeartLight® Endoscopic Ablation System at 80th Annual German Cardiac Society Meeting
Genoa Pharmaceuticals and McMaster University demonstrate inhaled pharmacokinetics enables improved pirfenidone activity with significant promise to enhance IPF treatment safety and tolerability
Cyclenium Pharma and Southern Research Institute Announce Drug Discovery and Development Collaboration
XBiotech Announces Phase I/II Study Results in Lancet Oncology
Volasertib, Boehringer Ingelheim's Investigational Oncology Compound, is Granted Orphan Drug Designation for Acute Myeloid Leukemia in the U.S. and EU
VentiRx Pharmaceuticals Announces the Completion of Patient Enrollment in Randomized, Placebo-controlled Phase 2 Trial of VTX-2337 in Combination with Pegylated-Liposomal Doxorubicin in Platinum-resistant Ovarian Cancer
Neurosurgery journal published study reinforces value of high-field iMRI English
Nora Therapeutics Announces $18 Million Series B Financing
Space institute funds eye tracking technology and software-enabled therapeutics for brain health
Astellas Pharma US, Inc. reaches agreement with U.S. Department of Justice
Sanguine to begin work with Mayo Clinic Bioservices English
Duquesne Research, Supported with $1.4 Million NIH Grant, Could Lead to Earlier Cancer Detection
ePharmaSolutions' ReferralPlus™ Increases Match Rate For Clinical Trial Volunteers By More than 66% During Pilot Studies With Major Pharmaceutical Consortium Members
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
Neuralstem Spinal Cord Injury Stem Cell Trial Approved To Commence At University Of California, San Diego
Osteoarthritis Study shows ActiPatch® Therapy Significantly Relieves Knee Pain
Phase 2a Clinical Study Data of AJM300, Oral alpha 4 Integrin Antagonist, Will Be Presented in Digestive Disease Week 2014
Esteemed Cell Biologist Selected to Receive America's Most Distinguished Prize in Medicine
inVentiv Health Clinical Engaged by IntelliCell Biosciences, a Regenerative Medicine Company, as Clinical Research Organization for Osteoarthritis IND
First CERAMENT™|G Study With Local Gentamicin Elution Shows Safe Bone Healing With Effective New Bone Ingrowth In Osteomyelitis Patients Spanish Spanish
Clinical Trial Investigates Cord Blood Stem Cells to Treat Cerebral Palsy in Children
Dermatology Development Experts bioskin Continues U.S. Expansion, Launches New Website

< Prev Next >
PR Newswire - United Business Media